Experiment: 2L34

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 (dimer) mM [U-100% 13C; U-100% 15N] DAP12 transmembrane peptide-5, 20 mM sodium phosphate-6, 25 mM [U-100% 2H] SDS-7, 250 mM [U-100% 2H] Foscholine-14-8	95% H2O/5% D2O	20	6.8	ambient	303
2	2D 1H-13C HSQC	0.5 (dimer) mM [U-100% 13C; U-100% 15N] DAP12 transmembrane peptide-5, 20 mM sodium phosphate-6, 25 mM [U-100% 2H] SDS-7, 250 mM [U-100% 2H] Foscholine-14-8	95% H2O/5% D2O	20	6.8	ambient	303
3	3D HNCA	0.5 (dimer) mM [U-100% 13C; U-100% 15N; U-80% 2H] DAP12 transmembrane peptide-1, 20 mM sodium phosphate-2, 25 mM SDS-3, 250 mM Foscholine-14-4	95% H2O/5% D2O	20	6.8	ambient	303
4	3D HN(CO)CA	0.5 (dimer) mM [U-100% 13C; U-100% 15N; U-80% 2H] DAP12 transmembrane peptide-1, 20 mM sodium phosphate-2, 25 mM SDS-3, 250 mM Foscholine-14-4	95% H2O/5% D2O	20	6.8	ambient	303
5	3D HNCACB	0.5 (dimer) mM [U-100% 13C; U-100% 15N; U-80% 2H] DAP12 transmembrane peptide-1, 20 mM sodium phosphate-2, 25 mM SDS-3, 250 mM Foscholine-14-4	95% H2O/5% D2O	20	6.8	ambient	303
6	3D HN(COCA)CB	0.5 (dimer) mM [U-100% 13C; U-100% 15N; U-80% 2H] DAP12 transmembrane peptide-1, 20 mM sodium phosphate-2, 25 mM SDS-3, 250 mM Foscholine-14-4	95% H2O/5% D2O	20	6.8	ambient	303
7	3D 1H-15N NOESY	0.5 (dimer) mM [U-100% 13C; U-100% 15N] DAP12 transmembrane peptide-5, 20 mM sodium phosphate-6, 25 mM [U-100% 2H] SDS-7, 250 mM [U-100% 2H] Foscholine-14-8	95% H2O/5% D2O	20	6.8	ambient	303
8	3D 1H-13C NOESY	0.5 (dimer) mM [U-100% 13C; U-100% 15N] DAP12 transmembrane peptide-5, 20 mM sodium phosphate-6, 25 mM [U-100% 2H] SDS-7, 250 mM [U-100% 2H] Foscholine-14-8	95% H2O/5% D2O	20	6.8	ambient	303
9	3D 1H-15N NOESY	0.5 (monomer) mM [U-100% 15N; U-100% 2H] DAP12 transmembrane peptide-9, 0.5 (monomer) mM [U-100% 13C] DAP12 transmembrane peptide-10, 25 mM [U-100% 2H] SDS-11, 250 mM [U-100% 2H] Foscholine-14-12, 20 mM sodium phosphate-13	95% H2O/5% D2O	20	6.8	ambient	303
10	2D 1H-13C HSQC	0.5 (dimer) mM [U-10% 13C] DAP12 transmembrane peptide-14, 25 mM [U-100% 2H] SDS-15, 250 mM [U-100% 2H] Foscholine-14-16, 20 mM sodium phosphate-17	95% H2O/5% D2O	20	6.8	ambient	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	Avance	600

NMR Refinement
Method	Details	Software
simulated annealing, molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	75
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	data analysis	XEASY		Bartels et al.
4	chemical shift assignment	XEASY		Bartels et al.
5	structure solution	X-PLOR_NIH		Schwieters, Kuszewski, Tjandra and Clore
6	refinement	X-PLOR_NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.